ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1393 National Cancer Institute Html en Cancer-Related Post-traumatic Stress (PDQ®)–Health Professional Version Expert-reviewed information summary about post-traumatic stress and related symptoms in cancer patients, cancer survivors, and their family members. Assessment and treatment of these symptoms are discussed.
traumatic event0.311819
cancer treatment0.301201
post-traumatic stress disorder0.298884
study0.281873
full-criteria PTSD group0.329802
PTSD trauma model0.338033
PTSD criteria0.318826
cancer experience0.272753
cancer treatment received.0.271124
intrusive thoughts0.407892
PTSD Checklist-Civilian Version0.325724
broad PTSD symptom0.316477
PTSD trauma0.338289
specific PTS symptoms0.273748
PTSD immediately postsurgery0.349332
PTSD symptoms0.490814
current PTSD0.319607
early-stage breast cancer0.412505
adult cancer patients0.298142
child cancer survivors0.27606
PTS symptoms0.347359
diagnostic criteria0.511308
PTSD patients0.326115
bone marrow transplant0.330974
mild-to-moderate cancer-related PTSD0.358971
structured clinical interview0.302585
PTSD-like symptoms0.416348
patients0.448951
cancer patients0.334316
post-traumatic symptoms0.263192
PTSD diagnostic criterion0.407584
breast cancer0.98286
DSM-IV PTSD syndrome0.373544
breast cancer survivors0.33396
acute stress disorder0.277841
lifetime PTSD0.33232
PTSD0.797398
symptoms0.617748
DSM-IV PTSD0.41474
PTSD module0.291206
cancer survivors0.345932
stress symptoms0.286797
metastatic breast cancer0.268733
precise PTSD symptoms0.406493
DSM-IV diagnostic criteria0.337351
early-stage cancer0.260629
CLICK HERE
1643 National Cancer Institute Html en Mistletoe Extracts (PDQ®)–Patient Version Mistletoe extracts have been studied in Europe as a treatment for many illness including cancer. Read about the use of mistletoe therapy in cancer patients and the results of clinical trials in this expert-reviewed summary.
cancer treatment0.498733
mistletoe extracts0.84177
European mistletoe species0.59742
cancer cell growth0.480977
Cancer Complementary0.499093
white blood cells0.478127
clinical trials0.814026
injectable mistletoe extracts0.584449
cancer information summary0.547122
alternative cancer therapies0.496047
National Center0.487589
CAM cancer research0.482862
mistletoe extract products0.586898
patients0.558663
cancer patients0.50887
body fight cancer0.488697
certain European countries0.486934
mistletoe0.936372
Integrative Health0.4867
NCI PDQ cancer0.515414
alternative medicine therapies0.509636
cancer information database0.494234
randomized clinical trials0.496538
Therapies Editorial Board0.492111
metastatic pancreatic cancer0.479516
mistletoe plant0.574134
injectable mistletoe0.604199
treatment0.516928
Complementary Therapies Editorial0.512225
human cancer cells0.481784
Drug Administration0.544399
Cancer Information Specialist0.48946
cancer cells0.492698
PDQ cancer information0.630287
Cancer Information Service0.543474
mistletoe extract0.769423
mistletoe dose0.56553
treatment clinical trials0.481986
National Cancer Institute0.675985
studies0.476699
alternative medicine0.586786
European mistletoe0.657219
mistletoe products0.583934
mistletoe lectins0.572067
cancer clinical trials0.506662
cell lung cancer0.478767
alternative therapies0.505915
cancer information summaries0.526674
CLICK HERE
1728 National Cancer Institute Html en End-of-Life Care for People Who Have Cancer A fact sheet that answers some of the questions patients, their family members, and caregivers may have about the end of life.
family members0.618911
family caregivers0.218961
advance directives0.30098
patients0.4187
people0.36964
life0.365064
caregivers0.584429
health care team0.768547
person0.99495
patient0.848579
hospice care0.29663
Related Resources section0.284122
loved ones0.266236
cancer0.462571
CLICK HERE
1819 National Cancer Institute Html es Tratamiento del tumor de Wilms y otros tumores renales infantiles (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del tumor de Wilms y otros tumores renales infantiles.
wilms tumor0.821427
wilms tumours0.50463
anomalías congénitas0.435681
gen blm0.427775
gen oncoinhibidor0.442787
gen oncosupresor h190.43309
gen drosha0.426257
anomalías cardíacas congénitas0.422372
Ahmed HU0.422578
tumores renales0.459976
gen ctr90.450784
gen cdkn1c0.42907
renal tumours0.428247
afección gen fenotipo0.433197
síndrome wagr0.961757
gen pax60.452923
Gen Wilms tumor0.633712
cánceres renales0.430685
síndrome congénito0.454197
Wilms Tumor Study0.602512
gen insulin growth0.431312
complejos génicos0.423036
anomalías renales0.500059
gen nsd10.428186
Beckwith-Wiedemann padecerán0.430165
Wilms Síndrome0.573396
gen wt10.557769
gen fbxw70.42494
Lancet Oncol0.427372
restos nefrógenos0.582325
Spring Harbor Laboratory0.432622
Cold Spring Harbor0.432647
síndromes wagr0.42334
gen ptch10.424282
efectos tardíos0.471463
tumor wilms0.630299
genes wt10.422664
dominio iiib0.434344
antecedentes familiares0.436654
Wilms anaplásico difuso0.515326
Wilms esporádico0.619115
mutaciones interruptoras0.593507
gen wtx0.481725
monoparental paterna0.424225
primary malignant non-wilms0.443665
gen tp530.452138
cánceres embrionarios.Las mutaciones0.471064
insuficiencia renal0.449112
células renales0.428025
CLICK HERE
1885 National Cancer Institute Html es Tratamiento de los cánceres poco comunes en la niñez (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento de los cánceres poco comunes en la niñez como los cánceres de la cabeza y el cuello, el tórax, el abdomen, el aparato reproductor, la piel y otros.
Group Childhood Cancer0.303634
Kadish Estadio Descripción0.300271
cancer statistics0.326488
pediatric rare tumors0.992234
patients with relapsed0.372754
cuadro clínico0.354432
Advanced Solid Tumors0.370423
estadificación posoperatoria0.711901
GPOH Pediatric Rare0.343984
cooperative study group0.363939
Sin embargo0.560837
ATA Task Force0.473736
Pediatric Patients with0.461297
Childhood Cancer Research0.442875
cuáles pacientes0.308117
Targeted Therapy Directed0.368386
Treating Pediatric Patients0.460472
or histiocytic disorders0.361605
Internet ClinicalTrials.gov0.45578
metástasis distantes0.307395
Children's Oncology Group0.570172
niños vs0.418573
International Classification0.392171
or refractory advanced0.367754
tiroides medular nem20.365237
very rare tumors0.299588
Refractory Advanced Solid0.36854
carcinoma nasofaríngeo0.834137
Pediatric Molecular Analysis0.447293
Pediatric MATCH0.923242
pediatric thyroid cancer0.456559
End Results0.382399
gammagrafía ósea0.326636
BRAF V600E0.354329
Childhood Cancer0.803535
relapsed or refractory0.373353
efectos tardíos0.368787
ATA Pediatric Risk0.307191
menudo metástasis0.316315
Riesgo pediátrico intermedio0.363674
rare pediatric tumors0.355894
PDQ Tratamiento0.348659
mutaciones braf v600e0.349145
NCI-COG Pediatric Molecular0.449773
gammagrafía diagnóstica0.608069
Clin Oncol0.421865
subgrupo xi0.374046
with relapsed or0.368469
european cooperative study0.370036
CLICK HERE
2032 National Cancer Institute Html es Exámenes de detección del cáncer de próstata (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca de las pruebas utilizadas para detectar el cáncer de próstata.
or watchful waiting0.527761
Prostate Cancer Group-40.536467
Koyama T0.514342
estudio erspc0.525762
Sin embargo0.633101
Resnick MJ0.514745
países cuáles factores0.523397
detección versus0.572904
Holmberg L0.514356
ensayo plco0.516954
Swedish Cancer Registry0.524495
Ahmed HU0.514521
jurisdicciones europeas colaboradoras0.519184
Preventive Services Task0.58607
Ovarian Cancer Screening0.580102
consiguiente tratamiento0.524752
Croswell JM0.515275
estudio prostate testing0.532458
Estados Unidos0.630717
centro göteborg0.570246
siguientes tasas0.517703
Prostate Cancer Prevention0.525333
PSA rutinarias0.626469
FJ Jr0.514192
evolución natural benigna0.523168
centro sueco göteborg0.523946
trascendencia clínica0.542862
Lancet Oncol0.516366
Eur Urol0.51628
End Results0.514418
Loeb S0.514034
Scandinavian Prostate Cancer0.583772
seguimiento diagnóstico0.518794
Gen Intern Med0.526679
lesiones prostáticas benignas0.525347
radical prostatectomy0.520653
Países Bajos0.556513
Fan KH0.51463
edad promedio0.515679
Chou R0.514768
PDQ Tratamiento0.51809
European Randomized Study0.573324
Intern Med0.549412
Steineck G0.514536
Services Task Force0.584434
prostate cancer0.738954
datos probatorios0.915311
Prostate Intervention Versus0.524636
Cancer Screening Trial0.580497
CLICK HERE
2055 National Cancer Institute Html es Obesidad y cáncer Hoja informativa que resume la evidencia que relaciona el sobrepeso y la obesidad al riesgo de cáncer.
body mass0.350143
Cancer Research Fund0.305964
Wang F0.302675
IMC Categoría0.303709
ligero aumento0.313291
anthropometric factors0.304184
pooled analysis from0.302634
Wang X0.302352
observational studies0.307777
male breast0.30286
risk factors0.317009
Kitahara CM0.305306
to modifiable factors0.302578
ovarian cancer0.313319
Estados Unidos0.306361
mechanisms linking obesity0.302489
PubMed Abstract0.981157
Women's Health Initiative0.305794
obesity prevalence among0.302851
endometrial cancer0.302426
Clinical Oncology0.31976
obesidad causa0.307215
prospective observational studies0.307481
International Journal0.314669
gallbladder cancer0.310353
body size throughout0.303222
United States0.304211
Renehan AG0.302352
Body Fatness0.302339
mayores riesgos0.303903
hormonal risk factors0.304977
dose-response meta-analysis0.303474
Cancer Research0.314608
PLoS Medicine0.303294
epidemiological studies0.304197
Cancer Prevention Trial0.306279
Current Oncology Reports0.302446
different risk factors0.304931
systematic review0.305695
Annual Review0.302768
risk according0.303418
Excess body weight0.303071
physical activity0.302433
pooled analysis0.316054
Cancer Institute0.315531
lymphedema risk factors0.304822
JAMA Oncology0.304192
prospective studies0.331726
New England Journal0.306423
CLICK HERE
3599 National Cancer Institute Html en The RAS Initiative NCI established the RAS Initiative to explore innovative approaches for attacking the proteins encoded by mutant forms of RAS genes and to ultimately create effective, new therapies for RAS-related cancers.
new therapies0.393067
RAS0.99043
RAS family0.739708
long way0.387894
oncogenic RAS0.6688
primary focus0.382845
RAS problem0.663793
industry0.314692
videos0.313651
mouse retroviruses0.388906
lab0.314136
percent0.362189
online forum RAS0.726513
RAS reagents0.661904
Douglas R. Lowy0.440325
RAS genes0.803577
Varmus’s vision0.381489
RAS hub0.667188
entire field0.379292
mutations0.318554
RAS oncogenes0.710337
proteins0.316387
Dear Colleagues0.397967
National Cancer Institute0.440589
pancreatic cancers0.432526
NCI director0.401396
RAS-related cancers0.425588
events0.31366
group0.314948
innovative approaches0.393563
goal0.328772
biology0.314898
academic researchers0.385896
RAS Central0.733488
virtual network0.380109
headway0.320561
Dr. Harold Varmus0.45561
blog posts0.37846
ras initiative0.905093
mutant forms0.396413
scientists0.313674
useful tools0.379773
human cancers0.42887
fascinating problem0.378178
colorectal cancers0.432751
concerted effort0.392419
time0.314762
CLICK HERE
16696 National Cancer Institute Html en Understanding Cervical Changes: A Health Guide for Women Explains abnormal Pap test, HPV test, and Pap/HPV cotest results. Treatment and follow-up care for abnormal cervical cancer screening results including ASC-US, AGC, LSIL, ASC-H, HSIL, AIS. Learn about colposcopy, types of biopsies, CIN, and HPV vaccine.
cervical screening test0.296143
cervical cancer cells0.337703
health care provider0.931179
cause cervical cancer0.303315
abnormal cervical changes0.298611
HPV types0.331542
hpv infections0.33479
abnormal cervical cell0.295805
different HPV test0.298266
cervical screening tests0.300727
cervical cells0.440061
HPV test work0.298659
test results0.460749
abnormal cervical screening0.340129
HPV test0.548179
cervical cancer screening0.419584
HPV test result0.334901
pap test0.669223
cervical cancer0.659605
abnormal test result0.292044
high-risk hpv types0.317446
HPV test results0.312992
high-risk HPV infection0.300301
women0.2963
treatment0.297209
abnormal cervical cells0.352195
HPV vaccination0.281435
Follow-Up Testing section0.335149
HPV vaccine0.303379
routine HPV testing0.291048
HPV0.555747
Pap test result0.316098
Low-risk HPV types0.299422
cervical cell changes0.36625
Cervical screening recommendations0.28727
abnormal pap test0.394575
abnormal cervical cancer0.33209
HPV vaccine series0.282155
Normal Pap test0.282878
Unsatisfactory Pap test0.281328
Possible next steps0.307487
common abnormal Pap0.287706
HPV tests0.293108
pap test results0.389844
HPV infection0.355986
abnormal cervical tissue0.293862
recent abnormal Pap0.289466
Cervical Cancer Treatment0.291973
CLICK HERE
17287 National Cancer Institute Html es Búsqueda de servicios médicos Sugerencias para elegir a un doctor o un establecimiento de tratamiento, opciones de cuidados médicos, atención a domicilio y cuidados para pacientes terminales.
teléfono al ACoS0.406963
practicantes miembros0.405783
línea quality check0.40869
es el doctor0.42878
Asociación Estadounidense0.423296
usa rayos0.406918
cirujanos miembros0.406162
cuenta los costos0.406987
capacitación de residencia0.407585
Atención Médica Asequible0.412098
Especialistas Médicos0.407972
la asociación médica estadounidense0.414538
información sobre cobertura0.405498
International Cancer Control0.40739
Colegio Estadounidense0.438106
seguro médico0.61246
Seguros Médicos0.413052
Oncología Clínica0.406552
pagar el tratamiento0.41398
paciente satisface los requisitos0.408803
Comisión Conjunta0.429316
Oncólogo radiólogo0.407999
los estados unidos0.40683
atención médica0.448896
Estados Unidos0.919617
información a disposición0.40585
cuestiones de viaje0.405374
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.